Literature DB >> 9491835

Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test.

A C Parker1, P Pritchard, T Preston, I Choonara.   

Abstract

AIMS: Carbamazepine is a known enzyme inducer. The aim of this study was to determine whether carbamazepine induces the metabolism of caffeine in children.
METHODS: Children due to receive carbamazepine for epilepsy were recruited into the study. The caffeine breath test was carried out prior to the administration of carbamazepine and after a minimum of 2-3 weeks therapy. Five children were studied and they received 200-600 mg carbamazepine daily.
RESULTS: The mean values of the 2 h cumulative labelled carbon dioxide were 3.47% before and 7.65% during carbamazepine. There was a significant increase in the percentage labelled caffeine exhaled as carbon dioxide during the administration of carbamazepine (Student's paired t-test, P < 0.05).
CONCLUSIONS: The results suggest that carbamazepine induces the metabolism of caffeine by the CYP1A2 pathway in the children studied.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491835      PMCID: PMC1873361          DOI: 10.1046/j.1365-2125.1998.00684.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Interaction between doxycycline and some antiepileptic drugs.

Authors:  O Penttilå; P J Neuvonen; K Aho; R Lehtovaara
Journal:  Br Med J       Date:  1974-06-01

2.  Clinical diagnosis with the stable isotope 13C in CO2 breath tests: methodology and fundamental considerations.

Authors:  D A Schoeller; J F Schneider; N W Solomons; J B Watkins; P D Klein
Journal:  J Lab Clin Med       Date:  1977-09

3.  Lack of inhibitory effect of cimetidine on caffeine metabolism in children using the caffeine breath test.

Authors:  A C Parker; P Pritchard; T Preston; A M Dalzell; I Choonara
Journal:  Br J Clin Pharmacol       Date:  1997-05       Impact factor: 4.335

4.  Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism.

Authors:  H Wietholtz; T Zysset; K Kreiten; D Kohl; R Büchsel; S Matern
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.

Authors:  P Crawford; D J Chadwick; C Martin; J Tjia; D J Back; M Orme
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

6.  The effect of age, gender, and sexual maturation on the caffeine breath test.

Authors:  G H Lambert; D A Schoeller; A N Kotake; C Flores; D Hay
Journal:  Dev Pharmacol Ther       Date:  1986

7.  Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.

Authors:  L Pichard; I Fabre; G Fabre; J Domergue; B Saint Aubert; G Mourad; P Maurel
Journal:  Drug Metab Dispos       Date:  1990 Sep-Oct       Impact factor: 3.922

8.  Rapid sample throughput for biomedical stable isotope tracer studies.

Authors:  T Preston; D C McMillan
Journal:  Biomed Environ Mass Spectrom       Date:  1988-10

9.  Effect of growth hormone therapy in growth hormone-deficient children on cytochrome P-450-dependent 3-N-demethylation of caffeine as measured by the caffeine 13CO2 breath test.

Authors:  L L Levitsky; D A Schoeller; G H Lambert; D V Edidin
Journal:  Dev Pharmacol Ther       Date:  1989

10.  Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin.

Authors:  K L Rost; H Brösicke; J Brockmöller; M Scheffler; H Helge; I Roots
Journal:  Clin Pharmacol Ther       Date:  1992-08       Impact factor: 6.875

View more
  12 in total

Review 1.  Drug trials in children: problems and the way forward.

Authors:  S Conroy; J McIntyre; I Choonara; T Stephenson
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

2.  Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism.

Authors:  Natasa Djordjevic; Roza Ghotbi; Slobodan Jankovic; Eleni Aklillu
Journal:  Eur J Clin Pharmacol       Date:  2010-07       Impact factor: 2.953

3.  Induction of the metabolism of etizolam by carbamazepine in humans.

Authors:  S Kondo; T Fukasawa; N Yasui-Furukori; T Aoshima; A Suzuki; Y Inoue; T Tateishi; K Otani
Journal:  Eur J Clin Pharmacol       Date:  2005-03-18       Impact factor: 2.953

Review 4.  Interactions between the cytochrome P450 system and the second-generation antipsychotics.

Authors:  Trevor I Prior; Glen B Baker
Journal:  J Psychiatry Neurosci       Date:  2003-03       Impact factor: 6.186

Review 5.  Olanzapine. Pharmacokinetic and pharmacodynamic profile.

Authors:  J T Callaghan; R F Bergstrom; L R Ptak; C M Beasley
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

Review 6.  Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for in vitro Human Cytochrome P450 Enzyme Induction.

Authors:  Miriam Naomi Jacobs; Barbara Kubickova; Eugene Boshoff
Journal:  Front Toxicol       Date:  2022-06-20

7.  Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes.

Authors:  Natasa Djordjevic; Roza Ghotbi; Leif Bertilsson; Slobodan Jankovic; Eleni Aklillu
Journal:  Eur J Clin Pharmacol       Date:  2007-12-22       Impact factor: 2.953

8.  CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy.

Authors:  Natasa Djordjevic; Dragana Dragas Milovanovic; Marija Radovanovic; Ivan Radosavljevic; Slobodan Obradovic; Mihajlo Jakovljevic; Dragan Milovanovic; Jasmina R Milovanovic; Slobodan Jankovic
Journal:  Eur J Clin Pharmacol       Date:  2016-01-14       Impact factor: 2.953

9.  Lack of a significant change in caffeine metabolism in underweight children as determined by the caffeine breath test.

Authors:  K A Oshikoya; H Sammons; K Smith; I Choonara
Journal:  Arch Dis Child       Date:  2015-04-20       Impact factor: 3.791

10.  PCB exposure and in vivo CYP1A2 activity among Native Americans.

Authors:  Edward F Fitzgerald; Syni-An Hwang; George Lambert; Marta Gomez; Alice Tarbell
Journal:  Environ Health Perspect       Date:  2005-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.